USPTO serial 98638835
PRINTORGANS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEASER, ANDREW C
- Law office
- TMO LAW OFFICE 117
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with PRINTORGANS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Surfside, FL, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jared L. DuJack
Jared L. DuJack Schmeiser, Olsen & Watts, LLP22 Century Hill Drive, Suite 302Latham, NY 12110United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Bioprinted organs comprising primarily living tissue for medical use; Bioprinted organs, namely ears comprising primarily living tissue for medical use; Bioprinted organs, namely, livers comprising primarily living tissue for medical use; Bioprinted organs, namely, kidneys comprising primarily living tissue for medical use; Bioprinted organs, namely portions of ears comprising primarily living tissue for medical use; Bioprinted organs, namely, portions of livers comprising primarily living tissue for medical use; Bioprinted organs, namely, portions of kidneys comprising primarily living tissue for medical use; Autologous bioprinted organs comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, ears comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, livers comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, kidneys comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, portions of ears comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, portions of livers comprising primarily living tissue for medical use; Autologous bioprinted organs, namely, portions of kidneys comprising primarily living tissue for medical use; Bioprinted structures for organs comprising primarily living tissue for medical use; Autologous bioprinted structures for organs comprising primarily living tissue for medical use; Ink for 3D bioprinters comprising primarily living cells or other biological materials for medical purposes | ACTIVE | — |
| 007 | 3D bioprinters; 6-axis 3D bioprinters | ACTIVE | — |
| 010 | Bioprinted organs comprising primarily synthetic material for medical use; Bioprinted organs, namely ears comprising primarily synthetic material for medical use; Bioprinted organs, namely, livers comprising primarily synthetic material for medical use; Bioprinted organs, namely, kidneys comprising primarily synthetic material for medical use; Bioprinted organs, namely portions of ears comprising primarily synthetic material for medical use; Bioprinted organs, namely, portions of livers comprising primarily synthetic material medical use; Bioprinted organs, namely, portions of kidneys comprising primarily synthetic material for medical use; Autologous bioprinted organs comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, ears comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, livers comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, kidneys comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, portions of ears comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, portions of livers comprising primarily synthetic material for medical use; Autologous bioprinted organs, namely, portions of kidneys comprising primarily synthetic material for medical use; Bioprinted structures for organs comprising primarily synthetic material for medical use; Autologous bioprinted structures for organs comprising primarily synthetic material for medical use; Ink for 3D bioprinters comprising primarily synthetic material or other biological materials for medical purposes | ACTIVE | — |
| 044 | Medical services, namely, organ replacement therapy; Medical services, namely, on demand organ replacement therapy; Medical services, namely, on demand organ replacement therapy using 3D bioprinting; Medical services, namely, on demand organ replacement therapy using autologous bioprinting | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PrintBio, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 007
- Other trademarks in Class 010
- Other trademarks in Class 044
- Similar marks named PRINTORGANS
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 27, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 2, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 2, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Sep 2, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 2, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 2, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 8, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 8, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 8, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 8, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2024 | NWAP | NEW APPLICATION ENTERED | — |